BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Pan H, Duan H, Chen J, Zhu Z, Fan J, Li P, Yang X, Pan W. Double-layered osmotic pump controlled release tablets of actarit: In vitro and in vivo evaluation. Asian J Pharm Sci 2019;14:340-8. [PMID: 32104464 DOI: 10.1016/j.ajps.2018.05.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Layek B, Mandal S. Natural polysaccharides for controlled delivery of oral therapeutics: a recent update. Carbohydrate Polymers 2020;230:115617. [DOI: 10.1016/j.carbpol.2019.115617] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
2 Liu H, Hu L, Singh RP, Dave B, Chen J, Yu J. Fabrication of a novel drug-resin combination device for controlled release of dextromethorphan hydrobromide. Colloids and Surfaces B: Biointerfaces 2020;189:110833. [DOI: 10.1016/j.colsurfb.2020.110833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ghislat G, Rahman T, Ballester PJ. Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit. Biomolecules 2020;10:E1570. [PMID: 33227945 DOI: 10.3390/biom10111570] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ogueri KS, Shamblin SL. Osmotic-controlled release oral tablets: technology and functional insights. Trends Biotechnol 2021:S0167-7799(21)00228-6. [PMID: 34689998 DOI: 10.1016/j.tibtech.2021.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Đuranović M, Obeid S, Madžarević M, Cvijić S, Ibrić S. Paracetamol extended release FDM 3D printlets: Evaluation of formulation variables on printability and drug release. Int J Pharm 2021;592:120053. [PMID: 33161041 DOI: 10.1016/j.ijpharm.2020.120053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gundu R, Pekamwar S, Shelke S, Kulkarni D, Gadade D, Shep S. Development and pharmacokinetic evaluation of osmotically controlled drug delivery system of Valganciclovir HCl for potential application in the treatment of CMV retinitis. Drug Deliv Transl Res 2022. [PMID: 35254625 DOI: 10.1007/s13346-022-01122-9] [Reference Citation Analysis]
7 Gundu R, Pekamwar S, Shelke S, Kulkarni D, Shep S. Development, optimization and pharmacokinetic evaluation of biphasic extended-release osmotic drug delivery system of trospium chloride for promising application in treatment of overactive bladder. Futur J Pharm Sci 2021;7. [DOI: 10.1186/s43094-021-00311-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gao S, Chen Y, Hu R, Lu W, Yu L, Chen J, Liu S, Guo Y, Shen Q, Wang B, Fang W. Visualized analysis and evaluation of simultaneous controlled release of metformin hydrochloride and gliclazide from sandwiched osmotic pump capsule. Drug Dev Ind Pharm 2020;46:1776-86. [PMID: 32895014 DOI: 10.1080/03639045.2020.1821047] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]